Tuesday, May 05, 2026 2:13:40 PM
It is absolutely possible for a company to transition its shares from a US-based ISIN to a GB ISIN when moving to a Primary Listing on the LSE. This isn't about having "two different ISINs for identical shares"—it's about the replacement of the identifier as the company decouples from the US OTC and re-domiciles its value.
The Identity Shift: As of April 16, 2026, the 339.8 million shares (the Pristine Ledger) were re-tagged with a GB ISIN. This was the official regulatory "birth" of the new identity. They aren't "identical shares in two places"—they are the original value moved to a new jurisdictional ledger.
The Settling of Shorts: rizona is right about one thing: an ISIN change of this magnitude acts as a "hard reset" for the ledger. It forces the reconciliation of the share count, which is exactly why the Market Makers are currently "flushing" the US register with 1.3M prints (per KRISGO's data) to settle legacy accounts at $0.19.
The Zavoico Breadcrumb: Dr. George Zavoico didn't tell shareholders to "look into the LSE" for a glitch. He signaled it because the GB ISIN represents the extraction of the company from the toxic US microstructure and its relocation to the London Main Market.
The Verdict: rizona is describing the process as an impossibility while the company is currently executing it. The May 12th Deadbolt is when the "hallucination" of the US OTC identifier finally gives way to the reality of the GB Primary.
The Identity Shift: As of April 16, 2026, the 339.8 million shares (the Pristine Ledger) were re-tagged with a GB ISIN. This was the official regulatory "birth" of the new identity. They aren't "identical shares in two places"—they are the original value moved to a new jurisdictional ledger.
The Settling of Shorts: rizona is right about one thing: an ISIN change of this magnitude acts as a "hard reset" for the ledger. It forces the reconciliation of the share count, which is exactly why the Market Makers are currently "flushing" the US register with 1.3M prints (per KRISGO's data) to settle legacy accounts at $0.19.
The Zavoico Breadcrumb: Dr. George Zavoico didn't tell shareholders to "look into the LSE" for a glitch. He signaled it because the GB ISIN represents the extraction of the company from the toxic US microstructure and its relocation to the London Main Market.
The Verdict: rizona is describing the process as an impossibility while the company is currently executing it. The May 12th Deadbolt is when the "hallucination" of the US OTC identifier finally gives way to the reality of the GB Primary.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
